Literature DB >> 2426690

Characterization of monoclonal antibodies raised against the prostatic cancer cell line PC-82.

M P Gallee, C C van Vroonhoven, H A van der Korput, T H van der Kwast, F J ten Kate, J C Romijn, J Trapman.   

Abstract

For production of monoclonal antibodies (McAbs), hybrid cells were prepared by fusion of spleen cells of BALB/c mice immunized with the human prostatic cancer cell line PC-82 and the P3-X6(3)Ag8.653 murine myeloma cell line. Supernatants of approximately 500 hybrid clones were screened for prostate specific antibodies using an ELISA on PC-82 cells. A selection of antibodies was further tested for their specificity on a large series of different tissues. A broad cross reactivity pattern was obtained. Most cross reactivity was with pancreatic tissue, kidney, and bowel. One antibody turned out to react with prostate stromal cells. Two McAbs (ER-Pr 1 and ER-Pr 2) reacted solely with prostatic epithelium. Monoclonal antibody affinity chromatography combined with SDS-PAGE showed that both antibodies were directed against a 35-kD protein. Immunoblotting revealed that this protein is identical to prostatic antigen (PA). The epitope detected by ER-Pr 1 and ER-Pr 2 was largely preserved after formalin-fixation of prostatic tissues which renders these antibodies very suitable for routine examination of tissue sections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426690     DOI: 10.1002/pros.2990090107

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Development of seven new human prostate tumor xenograft models and their histopathological characterization.

Authors:  W M van Weerden; C M de Ridder; C L Verdaasdonk; J C Romijn; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

2.  Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.

Authors:  M P Gallee; E Visser-de Jong; J A van der Korput; T H van der Kwast; F J ten Kate; F H Schroeder; J Trapman
Journal:  Urol Res       Date:  1990

Review 3.  Micrometastatic bone marrow involvement: detection and prognostic significance.

Authors:  S Braun; K Pantel
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

4.  Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells.

Authors:  R Riesenberg; R Oberneder; M Kriegmair; M Epp; U Bitzer; A Hofstetter; S Braun; G Riethmüller; K Pantel
Journal:  Histochemistry       Date:  1993-01

5.  Do neuroendocrine cells in human prostate cancer express androgen receptor?

Authors:  J L Krijnen; P J Janssen; J A Ruizeveld de Winter; H van Krimpen; F H Schröder; T H van der Kwast
Journal:  Histochemistry       Date:  1993-11

6.  Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

Authors:  J A Ruizeveld de Winter; P J Janssen; H M Sleddens; M C Verleun-Mooijman; J Trapman; A O Brinkmann; A B Santerse; F H Schröder; T H van der Kwast
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

7.  Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer.

Authors:  R Oberneder; R Riesenberg; M Kriegmair; U Bitzer; R Klammert; P Schneede; A Hofstetter; G Riethmüller; K Pantel
Journal:  Urol Res       Date:  1994

8.  Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies.

Authors:  M Mottolese; I Venturo; M Rinaldi; M Lopez; G Bigotti; M Benevolo; P G Natali
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.